Genotype matters: Personalized screening recommendations for germline CHEK2 variants.

Autor: Hernandez AR, Scheib R, Garber JE, Rana HQ, Bychkovsky BL

Publikováno v: Oncotarget [Oncotarget] 2024 Jul 10; Vol. 15, pp. 459-460. Date of Electronic Publication: 2024 Jul 10.

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception.

Autor: Bychkovsky BL; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. Brittany_Bychkovsky@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. Brittany_Bychkovsky@dfci.harvard.edu.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA. Brittany_Bychkovsky@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Brittany_Bychkovsky@dfci.harvard.edu., Lo MT; Ambry Genetics, Aliso Viejo, CA, USA., Yussuf A; Ambry Genetics, Aliso Viejo, CA, USA., Horton C; Ambry Genetics, Aliso Viejo, CA, USA., Hemyari P; Ambry Genetics, Aliso Viejo, CA, USA., LaDuca H; Ambry Genetics, Aliso Viejo, CA, USA., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Scheib R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Rana HQ; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jul; Vol. 200 (1), pp. 73.

Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis.

Autor: Laws A; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Katlin F; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Hans M; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Graichen M; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Kantor O; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Minami C; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bychkovsky BL; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Pace LE; Harvard Medical School, Boston, MA, USA.; Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Scheib R; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Garber JE; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. tking7@bwh.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. tking7@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. tking7@bwh.harvard.edu.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2023 Jan; Vol. 30 (1), pp. 68-77. Date of Electronic Publication: 2022 Sep 28.

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.

Autor: Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Agaoglu NB; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Genetics, Umraniye Training and Research Hospital, İstanbul, Turkey., Horton C; Ambry Genetics, Aliso Viejo, California., Zhou J; Ambry Genetics, Aliso Viejo, California., Yussuf A; Ambry Genetics, Aliso Viejo, California., Hemyari P; Ambry Genetics, Aliso Viejo, California., Richardson ME; Ambry Genetics, Aliso Viejo, California., Young C; Ambry Genetics, Aliso Viejo, California., LaDuca H; Ambry Genetics, Aliso Viejo, California., McGuinness DL; Rensselaer Polytechnic Institute, Troy, New York., Scheib R; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

Publikováno v: JAMA oncology [JAMA Oncol] 2022 Nov 01; Vol. 8 (11), pp. 1598-1606.

Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.

Autor: Ozdemir, Ozkan^1,2 (AUTHOR) gizem.senturk@live.acibadem.edu.tr, Bychkovsky, Brittany L.^3,4,5 (AUTHOR), Unal, Busra⁶ (AUTHOR) busraunalbav@gmail.com, Onder, Gizem^2,7 (AUTHOR) ufukamanvermez@gmail.com, Amanvermez, Ufuk^2,8 (AUTHOR) eylul.aydin@live.acibadem.edu.tr, Aydin, Eylul^2,8 (AUTHOR) ilayda.sahin@live.acibadem.edu.tr, Ergun, Berk⁹ (AUTHOR) berk.ergun@live.com, Sahin, Ilayda^2,10 (AUTHOR) ugur.ozbek@ibg.edu.tr, Gokbayrak, Merve¹¹ (AUTHOR) merve_ertan09@hotmail.com, Ugurtas, Cansu¹¹ (AUTHOR) cansu.ugurtas@gmail.com, Koroglu, Merve Nur¹² (AUTHOR) mervenurelif@gmail.com, Cakir, Berfin¹³ (AUTHOR) berfin.cakir@bilgiedu.net, Kalay, Irem⁶ (AUTHOR) dr.iremgenetic@gmail.com, Cine, Naci¹¹ (AUTHOR) nacicine@yahoo.com, Ozbek, Ugur^2,14 (AUTHOR), Rana, Huma Q.^3,4,5 (AUTHOR), Hatirnaz Ng, Ozden^1,2 (AUTHOR) ozden.hatirnaz@acibadem.edu.tr, Agaoglu, Nihat Bugra^3,6,15 (AUTHOR) ozden.hatirnaz@acibadem.edu.tr

Publikováno v: Cancers. Nov2024, Vol. 16 Issue 22, p3876. 17p.